A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
Clinical trial NCT06304974 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06304974
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-19
- Primary completion
- 2025-10-17
- Enrollment
- 497
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.